In most human tumours, the cell cycle regulators Cdk4/6-cyclinD are overactive. Here the authors use C. elegansas a model system to identify downstream regulators that are critical in the response of tumour cells to Cdk4/6 inhibitors.
- Inge The
- Suzan Ruijtenberg
- Sander van den Heuvel
